Member Info for Shukan

Covid-19 antibodies

NEW YORK CONNECTIONS =15P

go away u clueless nobody

it does not - global demand can not be met

come back in 18 months

83% up on my holding -sticking

Tops on twitter was told about it two years ago

YES BUT THE END GAME IS NOT TESTING

ITS NOT A TEST MATE

bunsenburner123 -A fool agrees with a fool.
Hemogenyx have working antibodies within the ApbHC humanised mouse modelling J&J large scale P2 testing underway for autoimmune disease.
Hemogenyx have working CDX antibodies (Leukaemia) within the ApbHC humanised mouse modelling ("the Global Pharma") licensing deal.
Hemogenyx developing neutralizing antibodies for Covid-19 plus other invading Pathogens keep the above in mind

anon3 - you seem well researched into the company LOL - another loser turns up

No TR1

I have no ramps on SP - just to say patience is the name of the game here - let the stock come to you

Covid -19 NEW YORK- Hemogenyx "front door busted down by Pharma" all becoming very interesting now

We are going to be hearing more about the HEMO MICE - big trial going on presently all initial stages were 100% satisfactory.

"Using its humanized mice, the Advanced peripheral blood Hematopoietic Chimera ("ApbHC"), which were developed to model blood and autoimmune diseases"

yes appears so

over two months of selling down chunks- drove the price down to a penny-

I LIKE TO DEAL WITH FACTS- seems the stock was split between the husband and wife- its the Husband he believes but not sure as other holdings are being sold off .

THIS STORY LINE IS TRUE - ABOUT THE BLOCK SELLER just spoken to Redmond .
Husband he believes, as the stock was split .

"I discussed in a previous thread but the seller is probably a creditor who is NOT INTERESTED IN MAKING A PROFIT WITH A BIG SHARE PRICE RISE! Look at the trades, they are in multiples of blocks of 50k. I am pretty certain the seller is the creditor who took control of 25-30Mil shares in Hemo back in December 2017 and are now selling those shares to settle the debt. Its going to take alot of new buyers to clear that number of shares..... Ideally the creditor would STOP selling for a few days, let the share price rise then continue selling but one could argue now is the ideal time for them to sell as there are so many buyers and profit to them equates money returned to the borrower.

Bottom line is, cant see them selling much below the price they are currently placing at each time as they need that to clear the debt. HOWEVER whenever that backlog IS cleared there may well be a shock when the influx of new stock to the market dries up. The biggest problem right now is both these events happening at once is concerning to the market wondering why the price has not shot up. Soon as Fool or something does some research and picks up a stock like this there will be no problem clearing that backlog."

gggg21 garbage post in any case - another one that hasn't a clue